2022 ASCRS CLINICAL SURVEY | 7
Based on those currently performing presbyopia-correcting IOLs (80%)
n=753
In patients implanted with a multifocal or extended depth of focus IOL, how much spherical
deviation from your intended target do you consider to be visually significant (i.e., likely to have
an impact on visual quality and patient satisfaction) in diopters?
≥0.25 D and ≤0.50 D
>0.50 D and ≤0.75 D
>0.75 D and ≤1.0 D
>1.0 D and ≤1.25 D
>1.25 D and ≤1.5 D
3%
0%
9%
43%
45%
Intended target is ≥0.50 D and ≤0.75 D by segment
2022
Practice location
U.S. 47%
International 41%
Years in practice
Early stage (0–5years) 38%
Mid stage (6–10 years) 46%
Last stage (11+ years) 47%
Perform majority
of surgeries in
Hospital outpatient
department (HOPD)
42%
Office 39%
Gender
Male 45%
Female 45%
What percentage of all cataract cases do you plan for "true" monovision, instead of performing
a presbyopia IOL procedure? (with a 1.0 D difference or greater between eyes aer surgery)?
Average % of cataract cases planned for
"true" monovision by segment
2022
Practice location
U.S. 9%
International 9%
Years in practice
Early stage (0–5years) 9%
Mid stage (6–10 years) 8%
Last stage (11+ years) 9%
Perform majority
of surgeries in
Hospital outpatient
department (HOPD)
8%
Office 9%
Gender
Male 9%
Female 9%
None
<5%
5–15%
16–25%
>25%
11%
7%
34%
4%
44%
average cataract cases planned
for "true" monovision with a
≥1.0 D difference
9%
Based on those currently performing presbyopia-correcting IOLs (80%)
n=753
